BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11057160)

  • 1. [Fetal warfarin syndrome].
    Sonoda T
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):105-7. PubMed ID: 11057160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fetal valproate syndrome].
    Sonoda T
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):96-8. PubMed ID: 11057157
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fetal hydantoin effects].
    Nakane Y
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):99-101. PubMed ID: 11057158
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fetal aminopterin syndrome].
    Harada M
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):88-9. PubMed ID: 11057154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fetal trimethadione effects].
    Nakane Y
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):94-5. PubMed ID: 11057156
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of congenital warfarin syndrome due to maternal drug administration during the pregnancy.
    Dilli D; Oğuz S; Dilmen U
    Genet Couns; 2011; 22(2):221-6. PubMed ID: 21848016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal warfarin syndrome.
    Hou JW
    Chang Gung Med J; 2004 Sep; 27(9):691-5. PubMed ID: 15605910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal warfarin syndrome.
    Sathienkijkanchai A; Wasant P
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S246-50. PubMed ID: 16856447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fetal warfarin syndrome].
    Nagai T
    Ryoikibetsu Shokogun Shirizu; 2001; (33):706-7. PubMed ID: 11462645
    [No Abstract]   [Full Text] [Related]  

  • 10. Etretinate embryotoxicity 7 months after discontinuation of treatment.
    Verloes A; Dodinval P; Koulischer L; Lambotte R; Bonnivert J
    Am J Med Genet; 1990 Nov; 37(3):437-8. PubMed ID: 2260582
    [No Abstract]   [Full Text] [Related]  

  • 11. [Retinoic acid embryopathy].
    Harada M
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):86-7. PubMed ID: 11057153
    [No Abstract]   [Full Text] [Related]  

  • 12. [The fetal primidone syndrome].
    Cohen A; Mundel G
    Harefuah; 1988 Feb; 114(4):171-3. PubMed ID: 3356390
    [No Abstract]   [Full Text] [Related]  

  • 13. [Warfarin embryopathy].
    Galil A; Biale Y; Bar-Ziv J
    Harefuah; 1984 Dec; 107(12):390-2. PubMed ID: 6532923
    [No Abstract]   [Full Text] [Related]  

  • 14. [The so-called "fetal alcoholism syndrome"].
    Lausecker C; Withofs L; Ritz N; Pennerath A
    Pediatrie; 1976 Dec; 31(8):741-7. PubMed ID: 1005006
    [No Abstract]   [Full Text] [Related]  

  • 15. Antenatal drugs affecting vitamin K status of the fetus and the newborn.
    Astedt B
    Semin Thromb Hemost; 1995; 21(4):364-70. PubMed ID: 8747699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin embryopathy--a case report.
    Lamontagne JM; Leclerc JE; Carrier C; Bureau M
    J Otolaryngol; 1984 Apr; 13(2):127-9. PubMed ID: 6726847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetotoxicity of warfarin anticoagulation.
    Mehndiratta S; Suneja A; Gupta B; Bhatt S
    Arch Gynecol Obstet; 2010 Sep; 282(3):335-7. PubMed ID: 20111969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Di Sala syndrome.
    Kumar M; Bhasker SK; Singh R; Kohli N; Kumar R
    BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy.
    Wong V; Cheng CH; Chan KC
    Am J Med Genet; 1993 Jan; 45(1):17-21. PubMed ID: 8418652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication development of a young child with foetal retinoid syndrome: a seven-year follow-up study.
    Kritzinger A; Steenkamp L
    S Afr J Commun Disord; 2006; 53():39-48. PubMed ID: 20218489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.